MeiraGTx Holdings (MGTX) Long-Term Investments (2021 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Long-Term Investments came in at $6.7 million in Q4 2025, little changed YoY from $6.7 million in Q4 2024, and little changed on a QoQ basis from $6.7 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Long-Term Investments (2021 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 5 years of Long-Term Investments data on file, last reported at $6.7 million in Q4 2025.
- Quarterly Long-Term Investments changed 0.0% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.7 million (changed 0.0% YoY) and the FY2025 annual result came in at $6.7 million, changed 0.0% from the prior year.
- Long-Term Investments held at $6.7 million in Q4 2025, from $6.7 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $6.8 million in Q4 2023 to a low of $1.5 million in Q1 2021.
- A 5-year average of $5.6 million and a median of $6.7 million in 2021 frame the typical range for Long-Term Investments.
- The widest YoY moves for Long-Term Investments: up 343.73% in 2022, down 77.49% in 2022.
- Tracing MGTX's Long-Term Investments over 5 years: stood at $6.7 million in 2021, then decreased by 4.96% to $6.3 million in 2022, then gained by 6.96% to $6.8 million in 2023, then decreased by 0.25% to $6.7 million in 2024, then changed by 0.0% to $6.7 million in 2025.
- The last three Long-Term Investments figures came in at $6.7 million (Q4 2025), $6.7 million (Q3 2025), and $6.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 39.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.84 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 6.75 Mn |
| Jun 30, 2025 | 6.75 Mn |
| Mar 31, 2025 | 6.75 Mn |
| Dec 31, 2024 | 6.75 Mn |
| Sep 30, 2024 | 6.77 Mn |
| Jun 30, 2024 | 6.77 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 6.33 Mn |
| Jun 30, 2023 | 6.33 Mn |
| Mar 31, 2023 | 6.33 Mn |
| Dec 31, 2022 | 6.33 Mn |
| Sep 30, 2022 | 6.66 Mn |
| Jun 30, 2022 | 6.66 Mn |
| Mar 31, 2022 | 6.66 Mn |
| Dec 31, 2021 | 6.66 Mn |
| Sep 30, 2021 | 6.67 Mn |
| Jun 30, 2021 | 6.67 Mn |